Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist

Pharmazie

Volumn 71, Issue 3, 2016, Pages 146-151

  Ronsisvalle, Simone ^a   Arico G ^a   Cova, A M ^a   Blanco, P ^a   Amata, E ^a   Pappalardo, M ^a   Pasquinucci, L ^a   Spadaro, A ^a   Ronsisvalle, N ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 (1 (1H INDOL 3 YL)PROPAN 2 YL) 3 (4 CHLOROPHENYL) 8 AZABICYCLO[3.2.1]OCTAN 3 OL; 8 (1 (1H INDOL 3 YL)PROPAN 2 YL) 3 PHENYL 8 AZABICYCLO[3.2.1]OCTAN 3 OL; BICYCLO[3.2.1]OCTANE DERIVATIVE; CASPASE 3; IBOGAINE; LIGAND; NALOXONE; PROCASPASE 3; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR; SIGMA-2 RECEPTOR;

A375 CELL LINE; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; COMPETITIVE BINDING ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL GUINEA PIG; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; NONHUMAN; RECEPTOR AFFINITY; ANIMAL; DRUG EFFECTS; ENZYME SPECIFICITY; ENZYMOLOGY; GUINEA PIG; ILEUM; MELANOMA, EXPERIMENTAL; METABOLISM; MUSCLE CONTRACTION; SMOOTH MUSCLE; TUMOR CELL LINE;

ANIMALS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GUINEA PIGS; HUMANS; ILEUM; IN VITRO TECHNIQUES; MELANOMA, EXPERIMENTAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RECEPTORS, SIGMA; SUBSTRATE SPECIFICITY;

EID: 84973369139     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2016.5685     Document Type: Article

References (28)

1. Ablordeppey SY, Fischer JB, Glennon RA (2000) Is a nitrogen atom an important pharmacophoric element in sigma ligand binding? Bioorg Med Chem 8: 2105-2111.
2. Antonini V, Prezzavento O, Coradazzi M, Marrazzo A, Ronsisvalle S, Arena E, Leanza G (2009) Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats. J Neurochem 109: 744-754.
3. Bowen WD, Vilner BJ, Williams W, Bertha CM, Kuehne ME, Jacobson AE (1995) Ibogaine and its congeners are sigma-2 receptor-selective ligands with moderate affinity. Eur J Pharmacol 278, 257-260.
4. Brent PJ, Pang GT (1995) Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur J Pharmacol 278: 151-160.
5. Brent PJ, Pang G, Little G, Dosen PJ, Van Helden DF (1996) The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. Biochem Biophys Res Commun 219: 219-226.
6. Crawford KW, Bowen WD (2002) Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 62: 313-322.
7. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V (1999) Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 289: 251-260.
8. 2 receptor ligands. Bioorg Med Chem 22: 393-397.
9. Haller JL, Panyutin I, Chaudhry A, Zeng C, Mach RH, Frank JA (2012) Sigma-2 receptor as potential indicator of stem cell differentiation. Mol Imaging Biol 14: 325-335.
10. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig E, Kampner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93: 8072-8077.
11. Huang YS, Lu HE, Zhang LJ, Wu Z (2014) Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy. Med Res Rev 34: 532-566.
12. John CS, Vilner BJ, Schwartz AM, W.D. Bowen J. (1996) Characterization of sigma receptor binding site in human biopsied solid breast tumors. J Nucl Med 37: 267P.
13. John CS, Vilner BJ, Gulden ME, Efange SMN, Langason RB, Moody TW, Bowen WD (1995) Synthesis and pharmacological characterization of 4-[125I]BP: A high affinity sigma receptor ligand for potential imaging of breast cancer. Cancer Res 55: 3022-3027.
14. John CS, Vilner BJ, Bowen WD (1994) Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. J Med Chem 37: 1737-1739.
15. Kinney GG, Harris EW, Ray R, Hudzik TJ (1995) Sigma2 Site-mediated inhibition of electrically evoked guinea pig ileum longitudinal muscle/myenteric plexus contractions. Eur J Pharmacol 294: 547-553.
16. Mach RH, Smith CR, Childers SR (1995) Ibogaine possesses a selective affinity for sigma 2 receptors. Life Sci 57: 57-62.
17. Marrazzo A, Prezzavento O, Pappalardo MS, Bousquet E, Iadanza M, Pike VW, Ronsisvalle G (2002) Synthesis of (+)- and (-)-cis-2-[(1-adamantylamino)-methyl]-1-phenylcyclopropane derivatives as high affinity probes for sigma1 and sigma2 binding sites. Farmaco 57: 45-53.
18. Marrazzo A, Cobos EJ, Parenti C, Aricò G, Marrazzo G, Ronsisvalle S, Pasquinucci L, Prezzavento O, Colabufo NA, Contino M, Gonzales LG, Scoto GM, Ronsisvalle G (2011) Novel potent and selective σ ligands: evaluation of their agonist and antagonist properties. J Med Chem 54: 3669-3673.
19. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-532.
20. Matsumoto RR (2007) Sigma Receptor: Historical Perspective and Background. Springer Science. New York, NY.
21. Moison D, De Deurwaerdère P, Cagnotto A, Marrazzo A, Prezzavento O, Ronsisvalle G, Mennini T, Spampinato (2003) Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo. Neuropharmacology 45: 945-953.
22. Mundey MK, Blaylock NA, Mason R, Glick SD, Maisonneuve IM, Wilson VG (2000) Pharmacological comparison of the effect of ibogaine and 18-methoxycoronaridine on isolated smooth muscle from the rat and guinea-pig. Br J Pharmacol 129: 1561-1568.
23. Perregaard J, Moltzen EK, Meier E, Sanchez C (1995) Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(Omega-aminoalkyl)-1H-indoles. J Med Chem 38: 1998-2008.
24. Prezzavento O, Campisi A, Ronsisvalle S, Li Volti G, Marrazzo A, Bramanti V, Cannavò G, Vanella L, Cagnotto A, Mennini T, Ientile R, Ronsisvalle G (2007) Novel sigma receptor ligands: synthesis and biological profile. J Med Chem 50: 951-961.
25. Prezzavento O, Campisi A, Parenti C, Ronsisvalle S, Arico G, Arena E, Pistolozzi M, Scoto GM, Bertucci C, Vanella A, Ronsisvalle G (2010) Synthesis and resolution of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(+/-)-PPCC)]: new sigma receptor ligands with neuroprotective effect. J Med Chem 53: 5881-5885.
26. Rodriguez-Mata M, Gotor-Fernandez V, Gonzalez-Sabin J, Rebolledo F, Gotor V (2011) Straightforward preparation of biologically active 1-aryl- and 1-heteroarylpropan-2-amines in enantioenriched form. Org Biomol Chem 9: 2274-2278.
27. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V (1998) Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 70: 922-931.
28. Willand N, Folleas B, Boutillon C, Verbraeken L, Gesquiere JC, Tartar A, Deprez B (2007) Efficient, two-step synthesis of N-substituted nortropinone derivatives. Tetrahedron Lett 48: 5007-5011.